Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Johnson & Johnson | 41 | 1 | 6 | 0 | €145.58 | €192.63 | 32.319% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €195.00 | 5.405% |
| Zoetis Inc. A | 22 | 1 | 1 | 0 | €173.50 | €196.17 | 13.064% |
| UCB S.A. | 1 | 0 | 1 | 0 | €166.95 | €210.00 | 25.786% |
| BeiGene Ltd ADR | 8 | 1 | 0 | 0 | €222.00 | €263.72 | 18.794% |
| Alnylam Pharmace. | 44 | 0 | 3 | 0 | €243.00 | €275.25 | 13.272% |
| Amgen Inc. | 29 | 1 | 3 | 1 | €290.50 | €304.82 | 4.929% |
| Icon plc | 27 | 0 | 5 | 0 | €269.00 | €327.46 | 21.733% |
| United Therapeutics | 29 | 1 | 2 | 0 | €321.60 | €341.70 | 6.249% |
| Medpace Holdings Inc | 18 | 0 | 2 | 0 | €312.80 | €408.19 | 30.494% |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 1 | 0 | €413.95 | €439.34 | 6.135% |
| arGEN X BV | 1 | 0 | 0 | 0 | €478.20 | €470.00 | -1.715% |
| Eli Lilly Corp. | 74 | 0 | 11 | 0 | €801.50 | €831.01 | 3.682% |
| Regeneron Pharmaceuticals Inc. | 53 | 1 | 7 | 0 | €922.80 | €1,080.6 | 17.101% |